Related Experiment Video

Updated: May 21, 2026

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays
07:42

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays

Published on: September 19, 2018

The evolving landscape of protein kinases in breast cancer: clinical implications

Alberto Ocaña1, Eitan Amir, Bostjan Seruga

  • 1Division of Medical Oncology and Hematology, Princess Margaret Hospital, Toronto, ON, Canada. alberto.ocana@uhn.ca

Cancer Treatment Reviews
|June 19, 2012
PubMed

Insights

Protein kinases are crucial in breast cancer development. This review covers druggable kinases, targeted therapies, and future research directions for kinase inhibitors in breast cancer treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Protein kinase dysfunction is implicated in diverse breast cancer subtypes.
  • HER2 (Human Epidermal growth factor Receptor 2) exemplifies kinase involvement in tumorigenesis.
  • Targeting protein kinases offers a promising therapeutic strategy for breast cancer.

Purpose of the Study:

  • To review current knowledge on protein kinases in breast cancer.
  • To highlight potentially druggable kinases and those in clinical trials.
  • To discuss targeted drug combinations and optimal integration of kinase inhibitors.

Main Methods:

  • Literature review of state-of-the-art knowledge on protein kinases in breast cancer.
  • Analysis of clinical studies involving kinase inhibitors.
  • Evaluation of the clinical development of kinase inhibitors.

Main Results:

  • Several protein kinases are key players in breast cancer pathophysiology.
  • Targeted agents against specific kinases are under clinical evaluation.
  • Combinatorial strategies and optimal integration of kinase inhibitors are being explored.

Conclusions:

  • Protein kinases represent critical targets for novel breast cancer therapies.
  • Further preclinical and clinical studies are needed to optimize kinase inhibitor development and application.
  • Understanding kinase roles is essential for advancing personalized breast cancer treatment.

More Related Videos

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors12:40

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

Published on: December 7, 2014

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...